Literature DB >> 8610148

High copy number I-Ab transgenes induce production of IgE through an interluekin 4-dependent mechanism.

S M Singer1, D T Umetsu, H O McDevitt.   

Abstract

To better understand the role of class II major histocompatibility complex molecules in both normal and autoimmune responses, we have produced a series of I-Ab transgenic mice. One of these transgenic constructs, designated NOD.PD, has the sequence of the NOD beta chain (Abeta(g7)) except at positions 56 and 57, where Pro-Asp replaces His-Ser. Several NOD.PD transgenic lines have been produced. One line of these mice carried a very high number of copies (>50) of the NOD.PD transgene. As has been described in other mice carrying high copy numbers of I-Ab transgenes, B-cell development was abnormal. The steady state numbers of mature B cells (IgM+/IgD(hi)) in the periphery were greatly reduced in transgenic mice compared to nontransgenic littermates. Surprisingly, rather than being accompanied by a generalized hypogammaglobulinemia, this B-cell deficiency was accompanied by elevated concentrations of IgG1 and IgE in the serum. Conversely, the levels of IgG2a were reduced in transgenic mice compared to nontransgenic littermates. Because this isotype pattern was characteristic of interleukin (IL)-4-induced class-switching, we then investigated the role of IL-4 in causing the observed phenotype. We crossed the high copy number transgenic mice with an IL-4-deficient strain of mice. As expected, the elevated levels of IgE in high copy number transgenic mice were eliminated when the IL-4 gene was inactivated. However, the reduction in the number of B cells was not ameliorated. These data indicate that the primary defect caused by the transgene was to reduce the number of B cells in these mice. This reduction was accompanied by a secondary increase in IL-4 production, which drove the remaining B cells toward the production of IgGl and IgE.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8610148      PMCID: PMC39740          DOI: 10.1073/pnas.93.7.2947

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides.

Authors:  S Buus; A Sette; S M Colon; C Miles; H M Grey
Journal:  Science       Date:  1987-03-13       Impact factor: 47.728

2.  Generation of agammaglobulinaemic mice by prenatal and postnatal exposure to polyclonal or monoclonal anti-IgM antibodies.

Authors:  A Cerny; C Heusser; S Sutter; A W Huegin; H Bazin; H Hengartner; R M Zinkernagel
Journal:  Scand J Immunol       Date:  1986-10       Impact factor: 3.487

3.  Induced differentiation of a transformed clone of Ly-1+ B cells by clonal T cells and antigen.

Authors:  G A Bishop; G Haughton
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

4.  Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens.

Authors:  V T Oi; P P Jones; J W Goding; L A Herzenberg; L A Herzenberg
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

Review 5.  The role of helper T cell products in mouse B cell differentiation and isotype regulation.

Authors:  R L Coffman; B W Seymour; D A Lebman; D D Hiraki; J A Christiansen; B Shrader; H M Cherwinski; H F Savelkoul; F D Finkelman; M W Bond
Journal:  Immunol Rev       Date:  1988-02       Impact factor: 12.988

6.  Inhibition of IgE binding to mast cells and basophils by monoclonal antibodies to murine IgE.

Authors:  M Baniyash; Z Eshhar
Journal:  Eur J Immunol       Date:  1984-09       Impact factor: 5.532

7.  The role of I-A/E molecules in B lymphocyte activation. I. Inhibition of lipopolysaccharide-induced responses by monoclonal antibodies.

Authors:  S Forsgren; G Pobor; A Coutinho; M Pierres
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

8.  Ia binding ligands and cAMP stimulate nuclear translocation of PKC in B lymphocytes.

Authors:  J C Cambier; M K Newell; L B Justement; J C McGuire; K L Leach; Z Z Chen
Journal:  Nature       Date:  1987 Jun 18-24       Impact factor: 49.962

9.  A severe combined immunodeficiency mutation in the mouse.

Authors:  G C Bosma; R P Custer; M J Bosma
Journal:  Nature       Date:  1983-02-10       Impact factor: 49.962

10.  Polyclonal activation of the murine immune system by a goat antibody to mouse IgD. IX. Induction of a polyclonal IgE response.

Authors:  F D Finkelman; C M Snapper; J D Mountz; I M Katona
Journal:  J Immunol       Date:  1987-05-01       Impact factor: 5.422

View more
  3 in total

1.  Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities.

Authors:  F Lühder; J Katz; C Benoist; D Mathis
Journal:  J Exp Med       Date:  1998-02-02       Impact factor: 14.307

2.  Embryonic Lethality in Homozygous Human Her-2 Transgenic Mice Due to Disruption of the Pds5b Gene.

Authors:  Carmen S M Yong; Janelle Sharkey; Belinda Duscio; Ben Venville; Wei-Zen Wei; Richard F Jones; Clare Y Slaney; Gisela Mir Arnau; Anthony T Papenfuss; Jan Schröder; Phillip K Darcy; Michael H Kershaw
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

3.  Expression of a Chimeric Antigen Receptor in Multiple Leukocyte Lineages in Transgenic Mice.

Authors:  Carmen S M Yong; Jennifer A Westwood; Jan Schröder; Anthony T Papenfuss; Bianca von Scheidt; Maria Moeller; Christel Devaud; Phillip K Darcy; Michael H Kershaw
Journal:  PLoS One       Date:  2015-10-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.